XENE
Xenon Pharmaceuticals Inc
$54.12
-1.02% ($0.56)
Volume
1.15M
52W High
$63.95
52W Low
$28.19
Market Cap
$5.54B
Next Earnings Report
Last Reported
May 12, 2026 Missed
Actual: -$1.17
vs. Consensus: -$1.13
Price Chart
EPS History: Consensus vs Actual
Last 11 quartersPrice Movement Around Earnings
Q1 2026
May 12, 2026
1-Day:
+1.60%
Q1 2026
May 11, 2026
1-Day:
-1.40%
Q1 2026
May 7, 2026
1-Day:
+0.79%
5-Day:
-1.79%
Q4 2025
Feb 26, 2026
1-Day:
-3.76%
5-Day:
-2.52%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q1'25 | $7.5M | +5,581.8% | 100.0% | -969.8% | -$65.0M |
| Q4'24 | $2.5M | +369.4% | 50.0% | -3,079.4% | -$65.7M |
| Q4'23 | $5.4M | -38.6% | 84.2% | -998.1% | -$44.7M |
| Q4'22 | $8,766 | -99.8% | -5,775.0% | -10,000.0% | -$37.4M |
| Q3'22 | $132,000 | -98.4% | -10,000.0% | -10,000.0% | -$37.2M |
| Q2'22 | $536,000 | -75.8% | -4,031.7% | -5,655.8% | -$31.2M |
| Q1'22 | $8.8M | +101.2% | -120.9% | -198.1% | -$19.7M |
| Q4'21 | $3.7M | -27.4% | -485.7% | -664.7% | -$25.6M |
Company Information
Symbol
XENE
Company
Xenon Pharmaceuticals Inc
Market Cap
$5.54B